Home Business China Takes Another Step in Its Effort to Dethrone Western Hegemony

China Takes Another Step in Its Effort to Dethrone Western Hegemony

Share
china-takes-another-step-in-its-effort-to-dethrone-western-hegemony
China Takes Another Step in Its Effort to Dethrone Western Hegemony
Share

Beijing adds to the list of ways it hopes to dethrone the dollar and America’s economic and financial dominance.U.S. dollar notes being counted next to stacks of 100 yuan (RMB) bank notes at a bank in Huaibei, China, On Sept. 24, 2013. STR/AFP via Getty Images11/19/2025|Updated: 11/19/2025CommentaryDespite China’s ongoing and severe economic problems, Chinese leader Xi Jinping continues to press his country and its yuan forward as a global alternative to the United States and its dollar.Milton Ezrati is a contributing editor at The National Interest, an affiliate of the Center for the Study of Human Capital at the University at Buffalo (SUNY), and chief economist for Vested, a New York-based communications firm. Before joining Vested, he served as chief market strategist and economist for Lord, Abbett & Co. He also writes frequently for City Journal and blogs regularly for Forbes. His latest book is “Thirty Tomorrows: The Next Three Decades of Globalization, Demographics, and How We Will Live.”Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...